NTLA-2001
Intellia Therapeutics
['cardiomyopathy', 'cardio', 'crispr']
first-in-human in vivo crispr/cas9 editing of the ttr gene by ntla-2001 in patients with transthyretin amyloid cardiomyopathy written by ! summary and analysis and more #aha2022 coverage below: 